aluates Reports

$ 0.0

Automative

Global Atosiban Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-38T3515

Global Atosiban Market Insights Forecast to 2028

BUY CHAPTERS

Global Atosiban Market Insights, Forecast to 2030

Code: QYRE-Auto-38T3515

Report

December 2024

Pages:91

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Ferring Pharmaceuticals

Sun Pharma

Shanghai Soho-Yiming Pharmaceuticals

EVER Pharma

Hangzhou Longshine Bio-Tech

Cayman Chemical

Neore Pharmaceutical

Atosiban Market

Atosiban is an inhibitor of the hormones oxytocin and vasopressin. It is used as an intravenous medication as a labour repressant (tocolytic) to halt premature labour.

The global Atosiban market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Atosiban is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Atosiban is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Atosiban is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key manufacturers of Atosiban include Ferring Pharmaceuticals, Sun Pharma, Shanghai Soho-Yiming Pharmaceuticals, EVER Pharma, Hangzhou Longshine Bio-Tech, Cayman Chemical and Neore Pharmaceutical, etc. In 2023, the global top five players had a share approximately % in terms of revenue.

Report Covers:

This report presents an overview of global market for Atosiban, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Atosiban, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Atosiban, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Atosiban sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Atosiban market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Atosiban sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Atosiban Market Report

Report Metric	Details
Report Name	Atosiban Market
Segment by Type	Injection Concentrate
Segment by Application	Hospital Pharmacies Online Pharmacies
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Shanghai Soho-Yiming Pharmaceuticals, EVER Pharma, Hangzhou Longshine Bio-Tech, Cayman Chemical, Neore Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Atosiban in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Atosiban manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Atosiban sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Atosiban Market report?

Ans: The main players in the Atosiban Market are Shanghai Soho-Yiming Pharmaceuticals, EVER Pharma, Hangzhou Longshine Bio-Tech, Cayman Chemical, Neore Pharmaceutical

What are the Application segmentation covered in the Atosiban Market report?

Ans: The Applications covered in the Atosiban Market report are Hospital Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Atosiban Market report?

Ans: The Types covered in the Atosiban Market report are Injection, Concentrate

Recommended Reports

API Market Trends

Therapeutic Drug Markets

Disease & Specialty Therapy

1 Study Coverage

1.1 Atosiban Product Introduction

1.2 Market by Type

1.2.1 Global Atosiban Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Injection

1.2.3 Concentrate

1.3 Market by Application

1.3.1 Global Atosiban Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospital Pharmacies

1.3.3 Online Pharmacies

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Atosiban Sales Estimates and Forecasts 2019-2030

2.2 Global Atosiban Revenue by Region

2.2.1 Global Atosiban Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Atosiban Revenue by Region (2019-2024)

2.2.3 Global Atosiban Revenue by Region (2025-2030)

2.2.4 Global Atosiban Revenue Market Share by Region (2019-2030)

2.3 Global Atosiban Sales Estimates and Forecasts 2019-2030

2.4 Global Atosiban Sales by Region

2.4.1 Global Atosiban Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Atosiban Sales by Region (2019-2024)

2.4.3 Global Atosiban Sales by Region (2025-2030)

2.4.4 Global Atosiban Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Atosiban Sales by Manufacturers

3.1.1 Global Atosiban Sales by Manufacturers (2019-2024)

3.1.2 Global Atosiban Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Atosiban in 2023

3.2 Global Atosiban Revenue by Manufacturers

3.2.1 Global Atosiban Revenue by Manufacturers (2019-2024)

3.2.2 Global Atosiban Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Atosiban Revenue in 2023

3.3 Global Key Players of Atosiban, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Atosiban Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Atosiban Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Atosiban, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Atosiban, Product Offered and Application

3.8 Global Key Manufacturers of Atosiban, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Atosiban Sales by Type

4.1.1 Global Atosiban Historical Sales by Type (2019-2024)

4.1.2 Global Atosiban Forecasted Sales by Type (2025-2030)

4.1.3 Global Atosiban Sales Market Share by Type (2019-2030)

4.2 Global Atosiban Revenue by Type

4.2.1 Global Atosiban Historical Revenue by Type (2019-2024)

4.2.2 Global Atosiban Forecasted Revenue by Type (2025-2030)

4.2.3 Global Atosiban Revenue Market Share by Type (2019-2030)

4.3 Global Atosiban Price by Type

4.3.1 Global Atosiban Price by Type (2019-2024)

4.3.2 Global Atosiban Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Atosiban Sales by Application

5.1.1 Global Atosiban Historical Sales by Application (2019-2024)

5.1.2 Global Atosiban Forecasted Sales by Application (2025-2030)

5.1.3 Global Atosiban Sales Market Share by Application (2019-2030)

5.2 Global Atosiban Revenue by Application

5.2.1 Global Atosiban Historical Revenue by Application (2019-2024)

5.2.2 Global Atosiban Forecasted Revenue by Application (2025-2030)

5.2.3 Global Atosiban Revenue Market Share by Application (2019-2030)

5.3 Global Atosiban Price by Application

5.3.1 Global Atosiban Price by Application (2019-2024)

5.3.2 Global Atosiban Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Atosiban Market Size by Type

6.1.1 US & Canada Atosiban Sales by Type (2019-2030)

6.1.2 US & Canada Atosiban Revenue by Type (2019-2030)

6.2 US & Canada Atosiban Market Size by Application

6.2.1 US & Canada Atosiban Sales by Application (2019-2030)

6.2.2 US & Canada Atosiban Revenue by Application (2019-2030)

6.3 US & Canada Atosiban Market Size by Country

6.3.1 US & Canada Atosiban Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Atosiban Sales by Country (2019-2030)

6.3.3 US & Canada Atosiban Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Atosiban Market Size by Type

7.1.1 Europe Atosiban Sales by Type (2019-2030)

7.1.2 Europe Atosiban Revenue by Type (2019-2030)

7.2 Europe Atosiban Market Size by Application

7.2.1 Europe Atosiban Sales by Application (2019-2030)

7.2.2 Europe Atosiban Revenue by Application (2019-2030)

7.3 Europe Atosiban Market Size by Country

7.3.1 Europe Atosiban Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Atosiban Sales by Country (2019-2030)

7.3.3 Europe Atosiban Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Atosiban Market Size

8.1.1 China Atosiban Sales (2019-2030)

8.1.2 China Atosiban Revenue (2019-2030)

8.2 China Atosiban Market Size by Application

8.2.1 China Atosiban Sales by Application (2019-2030)

8.2.2 China Atosiban Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Atosiban Market Size by Type

9.1.1 Asia Atosiban Sales by Type (2019-2030)

9.1.2 Asia Atosiban Revenue by Type (2019-2030)

9.2 Asia Atosiban Market Size by Application

9.2.1 Asia Atosiban Sales by Application (2019-2030)

9.2.2 Asia Atosiban Revenue by Application (2019-2030)

9.3 Asia Atosiban Sales by Region

9.3.1 Asia Atosiban Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Atosiban Revenue by Region (2019-2030)

9.3.3 Asia Atosiban Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Atosiban Market Size by Type

10.1.1 Middle East, Africa and Latin America Atosiban Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Atosiban Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Atosiban Market Size by Application

10.2.1 Middle East, Africa and Latin America Atosiban Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Atosiban Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Atosiban Sales by Country

10.3.1 Middle East, Africa and Latin America Atosiban Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Atosiban Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Atosiban Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 Ferring Pharmaceuticals

11.1.1 Ferring Pharmaceuticals Company Information

11.1.2 Ferring Pharmaceuticals Overview

11.1.3 Ferring Pharmaceuticals Atosiban Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 Ferring Pharmaceuticals Atosiban Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Ferring Pharmaceuticals Recent Developments

11.2 Sun Pharma

11.2.1 Sun Pharma Company Information

11.2.2 Sun Pharma Overview

11.2.3 Sun Pharma Atosiban Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 Sun Pharma Atosiban Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Sun Pharma Recent Developments

11.3 Shanghai Soho-Yiming Pharmaceuticals

11.3.1 Shanghai Soho-Yiming Pharmaceuticals Company Information

11.3.2 Shanghai Soho-Yiming Pharmaceuticals Overview

11.3.3 Shanghai Soho-Yiming Pharmaceuticals Atosiban Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 Shanghai Soho-Yiming Pharmaceuticals Atosiban Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Shanghai Soho-Yiming Pharmaceuticals Recent Developments

11.4 EVER Pharma

11.4.1 EVER Pharma Company Information

11.4.2 EVER Pharma Overview

11.4.3 EVER Pharma Atosiban Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 EVER Pharma Atosiban Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 EVER Pharma Recent Developments

11.5 Hangzhou Longshine Bio-Tech

11.5.1 Hangzhou Longshine Bio-Tech Company Information

11.5.2 Hangzhou Longshine Bio-Tech Overview

11.5.3 Hangzhou Longshine Bio-Tech Atosiban Sales, Price, Revenue and Gross Margin (2019-2024)

11.5.4 Hangzhou Longshine Bio-Tech Atosiban Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Hangzhou Longshine Bio-Tech Recent Developments

11.6 Cayman Chemical

11.6.1 Cayman Chemical Company Information

11.6.2 Cayman Chemical Overview

11.6.3 Cayman Chemical Atosiban Sales, Price, Revenue and Gross Margin (2019-2024)

11.6.4 Cayman Chemical Atosiban Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Cayman Chemical Recent Developments

11.7 Neore Pharmaceutical

11.7.1 Neore Pharmaceutical Company Information

11.7.2 Neore Pharmaceutical Overview

11.7.3 Neore Pharmaceutical Atosiban Sales, Price, Revenue and Gross Margin (2019-2024)

11.7.4 Neore Pharmaceutical Atosiban Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Neore Pharmaceutical Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Atosiban Industry Chain Analysis

12.2 Atosiban Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Atosiban Production Mode & Process

12.4 Atosiban Sales and Marketing

12.4.1 Atosiban Sales Channels

12.4.2 Atosiban Distributors

12.5 Atosiban Customers

13 Market Dynamics

13.1 Atosiban Industry Trends

13.2 Atosiban Market Drivers

13.3 Atosiban Market Challenges

13.4 Atosiban Market Restraints

14 Key Findings in The Global Atosiban Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Ferring Pharmaceuticals

Sun Pharma

Shanghai Soho-Yiming Pharmaceuticals

EVER Pharma

Hangzhou Longshine Bio-Tech

Cayman Chemical

Neore Pharmaceutical

List of Tables

Table 1. Global Atosiban Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Injection

Table 3. Major Manufacturers of Concentrate

Table 4. Global Atosiban Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 5. Global Atosiban Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global Atosiban Revenue by Region (2019-2024) & (US$ Million)

Table 7. Global Atosiban Revenue by Region (2025-2030) & (US$ Million)

Table 8. Global Atosiban Revenue Market Share by Region (2019-2024)

Table 9. Global Atosiban Revenue Market Share by Region (2025-2030)

Table 10. Global Atosiban Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 11. Global Atosiban Sales by Region (2019-2024) & (Kg)

Table 12. Global Atosiban Sales by Region (2025-2030) & (Kg)

Table 13. Global Atosiban Sales Market Share by Region (2019-2024)

Table 14. Global Atosiban Sales Market Share by Region (2025-2030)

Table 15. Global Atosiban Sales by Manufacturers (2019-2024) & (Kg)

Table 16. Global Atosiban Sales Share by Manufacturers (2019-2024)

Table 17. Global Atosiban Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 18. Global Atosiban Revenue Share by Manufacturers (2019-2024)

Table 19. Global Key Players of Atosiban, Industry Ranking, 2022 VS 2023 VS 2024

Table 20. Atosiban Price by Manufacturers 2019-2024 (USD/g)

Table 21. Global Atosiban Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 22. Global Atosiban by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Atosiban as of 2023)

Table 23. Global Key Manufacturers of Atosiban, Manufacturing Base Distribution and Headquarters

Table 24. Global Key Manufacturers of Atosiban, Product Offered and Application

Table 25. Global Key Manufacturers of Atosiban, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Atosiban Sales by Type (2019-2024) & (Kg)

Table 28. Global Atosiban Sales by Type (2025-2030) & (Kg)

Table 29. Global Atosiban Sales Share by Type (2019-2024)

Table 30. Global Atosiban Sales Share by Type (2025-2030)

Table 31. Global Atosiban Revenue by Type (2019-2024) & (US$ Million)

Table 32. Global Atosiban Revenue by Type (2025-2030) & (US$ Million)

Table 33. Global Atosiban Revenue Share by Type (2019-2024)

Table 34. Global Atosiban Revenue Share by Type (2025-2030)

Table 35. Atosiban Price by Type (2019-2024) & (USD/g)

Table 36. Global Atosiban Price Forecast by Type (2025-2030) & (USD/g)

Table 37. Global Atosiban Sales by Application (2019-2024) & (Kg)

Table 38. Global Atosiban Sales by Application (2025-2030) & (Kg)

Table 39. Global Atosiban Sales Share by Application (2019-2024)

Table 40. Global Atosiban Sales Share by Application (2025-2030)

Table 41. Global Atosiban Revenue by Application (2019-2024) & (US$ Million)

Table 42. Global Atosiban Revenue by Application (2025-2030) & (US$ Million)

Table 43. Global Atosiban Revenue Share by Application (2019-2024)

Table 44. Global Atosiban Revenue Share by Application (2025-2030)

Table 45. Atosiban Price by Application (2019-2024) & (USD/g)

Table 46. Global Atosiban Price Forecast by Application (2025-2030) & (USD/g)

Table 47. US & Canada Atosiban Sales by Type (2019-2024) & (Kg)

Table 48. US & Canada Atosiban Sales by Type (2025-2030) & (Kg)

Table 49. US & Canada Atosiban Revenue by Type (2019-2024) & (US$ Million)

Table 50. US & Canada Atosiban Revenue by Type (2025-2030) & (US$ Million)

Table 51. US & Canada Atosiban Sales by Application (2019-2024) & (Kg)

Table 52. US & Canada Atosiban Sales by Application (2025-2030) & (Kg)

Table 53. US & Canada Atosiban Revenue by Application (2019-2024) & (US$ Million)

Table 54. US & Canada Atosiban Revenue by Application (2025-2030) & (US$ Million)

Table 55. US & Canada Atosiban Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 56. US & Canada Atosiban Revenue by Country (2019-2024) & (US$ Million)

Table 57. US & Canada Atosiban Revenue by Country (2025-2030) & (US$ Million)

Table 58. US & Canada Atosiban Sales by Country (2019-2024) & (Kg)

Table 59. US & Canada Atosiban Sales by Country (2025-2030) & (Kg)

Table 60. Europe Atosiban Sales by Type (2019-2024) & (Kg)

Table 61. Europe Atosiban Sales by Type (2025-2030) & (Kg)

Table 62. Europe Atosiban Revenue by Type (2019-2024) & (US$ Million)

Table 63. Europe Atosiban Revenue by Type (2025-2030) & (US$ Million)

Table 64. Europe Atosiban Sales by Application (2019-2024) & (Kg)

Table 65. Europe Atosiban Sales by Application (2025-2030) & (Kg)

Table 66. Europe Atosiban Revenue by Application (2019-2024) & (US$ Million)

Table 67. Europe Atosiban Revenue by Application (2025-2030) & (US$ Million)

Table 68. Europe Atosiban Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 69. Europe Atosiban Revenue by Country (2019-2024) & (US$ Million)

Table 70. Europe Atosiban Revenue by Country (2025-2030) & (US$ Million)

Table 71. Europe Atosiban Sales by Country (2019-2024) & (Kg)

Table 72. Europe Atosiban Sales by Country (2025-2030) & (Kg)

Table 73. China Atosiban Sales by Type (2019-2024) & (Kg)

Table 74. China Atosiban Sales by Type (2025-2030) & (Kg)

Table 75. China Atosiban Revenue by Type (2019-2024) & (US$ Million)

Table 76. China Atosiban Revenue by Type (2025-2030) & (US$ Million)

Table 77. China Atosiban Sales by Application (2019-2024) & (Kg)

Table 78. China Atosiban Sales by Application (2025-2030) & (Kg)

Table 79. China Atosiban Revenue by Application (2019-2024) & (US$ Million)

Table 80. China Atosiban Revenue by Application (2025-2030) & (US$ Million)

Table 81. Asia Atosiban Sales by Type (2019-2024) & (Kg)

Table 82. Asia Atosiban Sales by Type (2025-2030) & (Kg)

Table 83. Asia Atosiban Revenue by Type (2019-2024) & (US$ Million)

Table 84. Asia Atosiban Revenue by Type (2025-2030) & (US$ Million)

Table 85. Asia Atosiban Sales by Application (2019-2024) & (Kg)

Table 86. Asia Atosiban Sales by Application (2025-2030) & (Kg)

Table 87. Asia Atosiban Revenue by Application (2019-2024) & (US$ Million)

Table 88. Asia Atosiban Revenue by Application (2025-2030) & (US$ Million)

Table 89. Asia Atosiban Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 90. Asia Atosiban Revenue by Region (2019-2024) & (US$ Million)

Table 91. Asia Atosiban Revenue by Region (2025-2030) & (US$ Million)

Table 92. Asia Atosiban Sales by Region (2019-2024) & (Kg)

Table 93. Asia Atosiban Sales by Region (2025-2030) & (Kg)

Table 94. Middle East, Africa and Latin America Atosiban Sales by Type (2019-2024) & (Kg)

Table 95. Middle East, Africa and Latin America Atosiban Sales by Type (2025-2030) & (Kg)

Table 96. Middle East, Africa and Latin America Atosiban Revenue by Type (2019-2024) & (US$ Million)

Table 97. Middle East, Africa and Latin America Atosiban Revenue by Type (2025-2030) & (US$ Million)

Table 98. Middle East, Africa and Latin America Atosiban Sales by Application (2019-2024) & (Kg)

Table 99. Middle East, Africa and Latin America Atosiban Sales by Application (2025-2030) & (Kg)

Table 100. Middle East, Africa and Latin America Atosiban Revenue by Application (2019-2024) & (US$ Million)

Table 101. Middle East, Africa and Latin America Atosiban Revenue by Application (2025-2030) & (US$ Million)

Table 102. Middle East, Africa and Latin America Atosiban Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 103. Middle East, Africa and Latin America Atosiban Revenue by Country (2019-2024) & (US$ Million)

Table 104. Middle East, Africa and Latin America Atosiban Revenue by Country (2025-2030) & (US$ Million)

Table 105. Middle East, Africa and Latin America Atosiban Sales by Country (2019-2024) & (Kg)

Table 106. Middle East, Africa and Latin America Atosiban Sales by Country (2025-2030) & (Kg)

Table 107. Ferring Pharmaceuticals Company Information

Table 108. Ferring Pharmaceuticals Description and Major Businesses

Table 109. Ferring Pharmaceuticals Atosiban Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)

Table 110. Ferring Pharmaceuticals Atosiban Product Model Numbers, Pictures, Descriptions and Specifications

Table 111. Ferring Pharmaceuticals Recent Developments

Table 112. Sun Pharma Company Information

Table 113. Sun Pharma Description and Major Businesses

Table 114. Sun Pharma Atosiban Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)

Table 115. Sun Pharma Atosiban Product Model Numbers, Pictures, Descriptions and Specifications

Table 116. Sun Pharma Recent Developments

Table 117. Shanghai Soho-Yiming Pharmaceuticals Company Information

Table 118. Shanghai Soho-Yiming Pharmaceuticals Description and Major Businesses

Table 119. Shanghai Soho-Yiming Pharmaceuticals Atosiban Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)

Table 120. Shanghai Soho-Yiming Pharmaceuticals Atosiban Product Model Numbers, Pictures, Descriptions and Specifications

Table 121. Shanghai Soho-Yiming Pharmaceuticals Recent Developments

Table 122. EVER Pharma Company Information

Table 123. EVER Pharma Description and Major Businesses

Table 124. EVER Pharma Atosiban Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)

Table 125. EVER Pharma Atosiban Product Model Numbers, Pictures, Descriptions and Specifications

Table 126. EVER Pharma Recent Developments

Table 127. Hangzhou Longshine Bio-Tech Company Information

Table 128. Hangzhou Longshine Bio-Tech Description and Major Businesses

Table 129. Hangzhou Longshine Bio-Tech Atosiban Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)

Table 130. Hangzhou Longshine Bio-Tech Atosiban Product Model Numbers, Pictures, Descriptions and Specifications

Table 131. Hangzhou Longshine Bio-Tech Recent Developments

Table 132. Cayman Chemical Company Information

Table 133. Cayman Chemical Description and Major Businesses

Table 134. Cayman Chemical Atosiban Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)

Table 135. Cayman Chemical Atosiban Product Model Numbers, Pictures, Descriptions and Specifications

Table 136. Cayman Chemical Recent Developments

Table 137. Neore Pharmaceutical Company Information

Table 138. Neore Pharmaceutical Description and Major Businesses

Table 139. Neore Pharmaceutical Atosiban Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)

Table 140. Neore Pharmaceutical Atosiban Product Model Numbers, Pictures, Descriptions and Specifications

Table 141. Neore Pharmaceutical Recent Developments

Table 142. Key Raw Materials Lists

Table 143. Raw Materials Key Suppliers Lists

Table 144. Atosiban Distributors List

Table 145. Atosiban Customers List

Table 146. Atosiban Market Trends

Table 147. Atosiban Market Drivers

Table 148. Atosiban Market Challenges

Table 149. Atosiban Market Restraints

Table 150. Research Programs/Design for This Report

Table 151. Key Data Information from Secondary Sources

Table 152. Key Data Information from Primary Sources

List of Figures

Figure 1. Atosiban Product Picture

Figure 2. Global Atosiban Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Atosiban Market Share by Type in 2023 & 2030

Figure 4. Injection Product Picture

Figure 5. Concentrate Product Picture

Figure 6. Global Atosiban Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Atosiban Market Share by Application in 2023 & 2030

Figure 8. Hospital Pharmacies

Figure 9. Online Pharmacies

Figure 10. Atosiban Report Years Considered

Figure 11. Global Atosiban Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Atosiban Revenue 2019-2030 (US$ Million)

Figure 13. Global Atosiban Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 14. Global Atosiban Revenue Market Share by Region (2019-2030)

Figure 15. Global Atosiban Sales 2019-2030 ((Kg)

Figure 16. Global Atosiban Sales Market Share by Region (2019-2030)

Figure 17. US & Canada Atosiban Sales YoY (2019-2030) & (Kg)

Figure 18. US & Canada Atosiban Revenue YoY (2019-2030) & (US$ Million)

Figure 19. Europe Atosiban Sales YoY (2019-2030) & (Kg)

Figure 20. Europe Atosiban Revenue YoY (2019-2030) & (US$ Million)

Figure 21. China Atosiban Sales YoY (2019-2030) & (Kg)

Figure 22. China Atosiban Revenue YoY (2019-2030) & (US$ Million)

Figure 23. Asia (excluding China) Atosiban Sales YoY (2019-2030) & (Kg)

Figure 24. Asia (excluding China) Atosiban Revenue YoY (2019-2030) & (US$ Million)

Figure 25. Middle East, Africa and Latin America Atosiban Sales YoY (2019-2030) & (Kg)

Figure 26. Middle East, Africa and Latin America Atosiban Revenue YoY (2019-2030) & (US$ Million)

Figure 27. The Atosiban Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 28. The Top 5 and 10 Largest Manufacturers of Atosiban in the World: Market Share by Atosiban Revenue in 2023

Figure 29. Global Atosiban Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 30. Global Atosiban Sales Market Share by Type (2019-2030)

Figure 31. Global Atosiban Revenue Market Share by Type (2019-2030)

Figure 32. Global Atosiban Sales Market Share by Application (2019-2030)

Figure 33. Global Atosiban Revenue Market Share by Application (2019-2030)

Figure 34. US & Canada Atosiban Sales Market Share by Type (2019-2030)

Figure 35. US & Canada Atosiban Revenue Market Share by Type (2019-2030)

Figure 36. US & Canada Atosiban Sales Market Share by Application (2019-2030)

Figure 37. US & Canada Atosiban Revenue Market Share by Application (2019-2030)

Figure 38. US & Canada Atosiban Revenue Share by Country (2019-2030)

Figure 39. US & Canada Atosiban Sales Share by Country (2019-2030)

Figure 40. U.S. Atosiban Revenue (2019-2030) & (US$ Million)

Figure 41. Canada Atosiban Revenue (2019-2030) & (US$ Million)

Figure 42. Europe Atosiban Sales Market Share by Type (2019-2030)

Figure 43. Europe Atosiban Revenue Market Share by Type (2019-2030)

Figure 44. Europe Atosiban Sales Market Share by Application (2019-2030)

Figure 45. Europe Atosiban Revenue Market Share by Application (2019-2030)

Figure 46. Europe Atosiban Revenue Share by Country (2019-2030)

Figure 47. Europe Atosiban Sales Share by Country (2019-2030)

Figure 48. Germany Atosiban Revenue (2019-2030) & (US$ Million)

Figure 49. France Atosiban Revenue (2019-2030) & (US$ Million)

Figure 50. U.K. Atosiban Revenue (2019-2030) & (US$ Million)

Figure 51. Italy Atosiban Revenue (2019-2030) & (US$ Million)

Figure 52. Russia Atosiban Revenue (2019-2030) & (US$ Million)

Figure 53. China Atosiban Sales Market Share by Type (2019-2030)

Figure 54. China Atosiban Revenue Market Share by Type (2019-2030)

Figure 55. China Atosiban Sales Market Share by Application (2019-2030)

Figure 56. China Atosiban Revenue Market Share by Application (2019-2030)

Figure 57. Asia Atosiban Sales Market Share by Type (2019-2030)

Figure 58. Asia Atosiban Revenue Market Share by Type (2019-2030)

Figure 59. Asia Atosiban Sales Market Share by Application (2019-2030)

Figure 60. Asia Atosiban Revenue Market Share by Application (2019-2030)

Figure 61. Asia Atosiban Revenue Share by Region (2019-2030)

Figure 62. Asia Atosiban Sales Share by Region (2019-2030)

Figure 63. Japan Atosiban Revenue (2019-2030) & (US$ Million)

Figure 64. South Korea Atosiban Revenue (2019-2030) & (US$ Million)

Figure 65. China Taiwan Atosiban Revenue (2019-2030) & (US$ Million)

Figure 66. Southeast Asia Atosiban Revenue (2019-2030) & (US$ Million)

Figure 67. India Atosiban Revenue (2019-2030) & (US$ Million)

Figure 68. Middle East, Africa and Latin America Atosiban Sales Market Share by Type (2019-2030)

Figure 69. Middle East, Africa and Latin America Atosiban Revenue Market Share by Type (2019-2030)

Figure 70. Middle East, Africa and Latin America Atosiban Sales Market Share by Application (2019-2030)

Figure 71. Middle East, Africa and Latin America Atosiban Revenue Market Share by Application (2019-2030)

Figure 72. Middle East, Africa and Latin America Atosiban Revenue Share by Country (2019-2030)

Figure 73. Middle East, Africa and Latin America Atosiban Sales Share by Country (2019-2030)

Figure 74. Brazil Atosiban Revenue (2019-2030) & (US$ Million)

Figure 75. Mexico Atosiban Revenue (2019-2030) & (US$ Million)

Figure 76. Turkey Atosiban Revenue (2019-2030) & (US$ Million)

Figure 77. Israel Atosiban Revenue (2019-2030) & (US$ Million)

Figure 78. GCC Countries Atosiban Revenue (2019-2030) & (US$ Million)

Figure 79. Atosiban Value Chain

Figure 80. Atosiban Production Process

Figure 81. Channels of Distribution

Figure 82. Distributors Profiles

Figure 83. Bottom-up and Top-down Approaches for This Report

Figure 84. Data Triangulation

Figure 85. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Atosiban Acetate API Market Research Report 2024

Global Oxytocin Receptor Inhibitors Market Research Report 2024

Global Carbetocin API Market Research Report 2025

Oxytocic Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vasopressin Antagonist Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Carbetocin API for Human Use Market Research Report 2025

Global Oxytocic Pharmaceuticals Market Research Report 2024

Global Carbetocin for Injection Market Research Report 2024

Global Pharmaceutical Grade Carbetocin Market Research Report 2025

Global Carbetocin Injection Market Research Report 2024

Global Oxytocin Injection Market Research Report 2024

Global Levosimendan Injection Market Research Report 2024

Global Enalaprilat Market Research Report 2024

Global Fosinopril Sodium Tablets Market Research Report 2024

Global Atosiban Acetate Injection Market Research Report 2024

Global Posterior Pituitary for Injection Market Research Report 2024

Global Oxytocin Market Insights Forecast to 2030

Global Solifenacin Succinate Drug Market Insights Forecast to 2030

Global Alfuzosin Market Insights Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-19A18322

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-3E3525

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-35T3049

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-33Y1801

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Atosiban Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-38T3515

Global Atosiban Market Insights, Forecast to 2030

FEATURED COMPANIES

Atosiban Market

Scope of Atosiban Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Atosiban Market report?

What are the Application segmentation covered in the Atosiban Market report?

What are the Type segmentation covered in the Atosiban Market report?

Recommended Reports

API Market Trends

Therapeutic Drug Markets

Disease & Specialty Therapy

FEATURED COMPANIES

RELATED REPORTS